SS Innovations International, Inc.
NASDAQ: SSIIGurugram, Haryana, US · Founded 2015 · Florida corporation · 464 employees on LinkedIn · 1 known investors
SS Innovations International develops surgical robotic systems, including the SSi Mantra platform, for use in robotic surgery such as cardiothoracic procedures. The medical technology company focuses on making robotic surgery more affordable and accessible to underserved populations.
Founders & leadership
SS Innovations International, Inc. was founded in 2015 by Dr. Sudhir Srivastava.
DS
Dr. Sudhir SrivastavainFounder, Chairman and CEOA cardiothoracic surgeon by training, he has led robotic surgery ventures in India since 2011, serving as chairman, CEO and managing director of both the International Centre for Robotic Surgery and Telegnosis Private Limited. He founded SS Innovations in 2014 to develop surgical robotic systems.
MR
Milan RaoGlobal Chief Operating Officer and Chief Financial Officer
VP
Vishwajyoti P. SrivastavaChief Executive Officer - Asia Pacific and Director
BF
Barry F. CohenChief Operating Officer - Americas and Director
VS
Vishwa Srivastava, MDChief Executive Officer - APAC
Board
TA
Tim AdamsBoard director
MA
SS
S.P. SomashekharBoard director
FH
Investors · 1
Reported raises · per SEC filings
Form D private placements$21.8M disclosed across 4 rounds · 2016–2026
▶$18.6MraisedMar 2026 · 25 investors · BiotechnologyRule 506(b)
▶$18.6MraisedMar 2026 · 25 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Milan RaoExecutive Officer
- Tim AdamsDirector
- Vishwajyoti P. SrivastavaExecutive Officer, Director
- Mylswamy AnnaduraiDirector
- Barry F. CohenExecutive Officer, Director
- S.P. SomashekharDirector
- Sudhir Prem SrivastavaExecutive Officer, Director
- Frederic H. MollDirector
- Offering amount
- $18.6M
- Amount sold
- $18.6M
- Minimum investment
- $75K
- Sales commissions
- $175K
- Placement agents
- Roth Capital Partners, LLC
- First sale
- Mar 2026
- Incorporated
- Corporation, Florida
- Federal exemptions
- 06b
▶$2.5MraisedFeb 2024 · 5 investors · BiotechnologyRule 506(b)
▶$2.5MraisedFeb 2024 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Anup Kumar SethiExecutive Officer
- Barry F. CohenExecutive Officer, Director
- Vishwajyoti P. SrivastavaExecutive Officer, Director
- Sudhir Prem SrivastavaExecutive Officer, Director
- Mylswamy AnnaduraiDirector
- Somashekhar S.P.Director
- Offering amount
- $4M
- Amount sold
- $2.5M
- Minimum investment
- $100K
- First sale
- Feb 2024
- Incorporated
- Corporation, Florida
- Federal exemptions
- 06b
▶$542.3KraisedOct 2017 · 26 investors · Other TechnologyRule 506(b)
▶$542.3KraisedOct 2017 · 26 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Peter CarnegieDirector
- Albert Christian SchauerExecutive Officer
- Barry CohenExecutive Officer, Director
- Ray PowersExecutive Officer
- Alexandre S. ClugExecutive Officer
- Nikhil ShahDirector
- Nicole Bergman-FongExecutive Officer
- Offering amount
- $542.3K
- Amount sold
- $542.3K
- Minimum investment
- $1.3K
- First sale
- Oct 2017
- Incorporated
- Corporation, Florida, 2015
- Federal exemptions
- 06b
▶$225KraisedJun 2016 · 5 investors · Other TechnologyRule 506(b)
▶$225KraisedJun 2016 · 5 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Barry CohenExecutive Officer, Director, Promoter
- Offering amount
- $500K
- Amount sold
- $225K
- Minimum investment
- $100K
- First sale
- May 2016
- Incorporated
- Corporation, Florida, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed events$38.4Mvaluation at IPOJul 2017 · $2.00/share · S-1/A
filing ↗Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Competitors · 2
by search overlap
Seeking Alpha5 shared keywordsSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
Quiverquant5 shared keywordsQuiver Quantitative scrapes and aggregates alternative stock market data from across the internet into a free web dashboard. It targets retail investors, giving non-professional traders access to alternative data typically reserved for institutional money managers.
Companies competing with SS Innovations International, Inc. for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does SS Innovations International, Inc. do?
- SS Innovations International develops surgical robotic systems, including the SSi Mantra platform, for use in robotic surgery such as cardiothoracic procedures. The medical technology company focuses on making robotic surgery more affordable and accessible to underserved populations.
- Who founded SS Innovations International, Inc.?
- SS Innovations International, Inc. was founded by Dr. Sudhir Srivastava in 2015.
- Who are SS Innovations International, Inc.'s investors?
- SS Innovations International, Inc.'s investors include Sonder Futures.
- How much funding has SS Innovations International, Inc. raised?
- SS Innovations International, Inc. has disclosed $21.8M raised across 4 rounds.
- Where is SS Innovations International, Inc. headquartered?
- SS Innovations International, Inc. is headquartered in Gurugram, Haryana, US.